The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...

Given the advantages over its rivals, Regeneron is hopeful its bispecific antibody will become the new standard of care for ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

That’s where anti-inflammatory therapeutics come into play, offering hope for millions of people living with chronic inflammation. The global anti-inflammatory therapeutics market size was $98,026 ...

While current methods of isolating islet cells for transplantation strip away the structural scaffold that supports the cells ...

Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...